• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MEDT 研究重氮甲烷与 Psilostachyin 的 1,3-DC 反应以及一些吡唑啉衍生物与 nCoV-2 M 蛋白酶相互作用的研究。

MEDT study of the 1,3-DC reaction of diazomethane with Psilostachyin and investigation about the interactions of some pyrazoline derivatives with protease (M) of nCoV-2.

机构信息

Molecular Modeling and Spectroscopy Research Team, Department of Chemistry, Faculty of Sciences, Chouaïb Doukkali University, El Jadida, Morocco; LS3MN2E, Department of Chemistry, Mohammed V University, Faculty of Sciences Rabat, Morocco.

Molecular Modeling and Spectroscopy Research Team, Department of Chemistry, Faculty of Sciences, Chouaïb Doukkali University, El Jadida, Morocco.

出版信息

J Mol Graph Model. 2021 Jan;102:107763. doi: 10.1016/j.jmgm.2020.107763. Epub 2020 Sep 24.

DOI:10.1016/j.jmgm.2020.107763
PMID:33069124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7515590/
Abstract

The molecular electronic density theory (MEDT) was invested to elucidate the chemo-, regio- and stereo-selectivity of the 1,3-dipolar cycloaddition between Diazomethane (DZM) and Psilostachyin (PSH). The DFT method at B3LYP/6-31 + G (d,p) level of theory was used. Reactivity indices, transition structures theory, IGM and ELF analysis were employed to reveal the mechanism of the reaction. The addition of DZM to PSH takes place through a one-step mechanism and an asynchronous transition states. Eight possible addition channels of reaction were investigated (addition of C (sp2) to Diazomethane at C4, C5, C6 or C7). The addition of C (sp2) at C5 leading to P1 product is the preferred channel. The addition of ether does not affect the chemo-, regio- and stereo-selectivity of the reaction. Analysis of transfer of charges along the IRC path associated with the P1 product shows a polar character for the studied reaction. We have also used the noncovalent interaction (NCI) which is very helpful to reveal the most favored addition channel of the reaction, by analyzing the weak interactions in different TSs. Finally, we investigate about the potential of inhibition of some pyrazoline compounds against COVID-19-M by performing a molecular docking calculations.

摘要

采用密度泛函理论(DFT)中的 B3LYP/6-31 + G(d,p)水平对叠氮甲烷(DZM)与毛叶云香碱(PSH)之间的 1,3-偶极环加成的化学选择性、区域选择性和立体选择性进行了研究。运用反应指数、过渡态理论、IGM 和 ELF 分析揭示了反应机理。DZM 与 PSH 的加成通过一步机制和异步过渡态进行。研究了反应的八种可能的加成通道(Diazomethane 加成到 C4、C5、C6 或 C7 上的 C(sp2))。加成到 C5 上生成 P1 产物的 C(sp2)加成是首选通道。醚的加成不影响反应的化学选择性、区域选择性和立体选择性。与 P1 产物相关的 IRC 路径上电荷转移的分析表明,该反应具有极性特征。我们还使用非共价相互作用(NCI)来分析不同过渡态中的弱相互作用,这对揭示反应最有利的加成通道非常有帮助。最后,我们通过进行分子对接计算,研究了一些吡唑啉化合物对 COVID-19-M 的潜在抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/6117bf1010ae/gr10b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/e42a1cc66782/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/3056745ee04f/sc1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/38ddafc1ccf2/sc2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/317a88f5bf85/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/0f80f7b017ba/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/7b2239c32318/sc3a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/884bbd3f9960/sc3b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/a0b65c23c6f4/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/3a183a5fc2e7/gr4a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/4ba2f568dfaf/gr4b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/a9b356403a78/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/83a160fe91ba/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/ec285774a06c/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/4b6ec36b2249/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/98be66918d9e/gr9a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/1186d7aa6ee1/gr9b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/3acaef54f9f4/gr10a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/6117bf1010ae/gr10b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/e42a1cc66782/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/3056745ee04f/sc1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/38ddafc1ccf2/sc2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/317a88f5bf85/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/0f80f7b017ba/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/7b2239c32318/sc3a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/884bbd3f9960/sc3b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/a0b65c23c6f4/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/3a183a5fc2e7/gr4a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/4ba2f568dfaf/gr4b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/a9b356403a78/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/83a160fe91ba/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/ec285774a06c/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/4b6ec36b2249/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/98be66918d9e/gr9a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/1186d7aa6ee1/gr9b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/3acaef54f9f4/gr10a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a52a/7515590/6117bf1010ae/gr10b_lrg.jpg

相似文献

1
MEDT study of the 1,3-DC reaction of diazomethane with Psilostachyin and investigation about the interactions of some pyrazoline derivatives with protease (M) of nCoV-2.MEDT 研究重氮甲烷与 Psilostachyin 的 1,3-DC 反应以及一些吡唑啉衍生物与 nCoV-2 M 蛋白酶相互作用的研究。
J Mol Graph Model. 2021 Jan;102:107763. doi: 10.1016/j.jmgm.2020.107763. Epub 2020 Sep 24.
2
Identification of Pyrazole Derivatives of Usnic Acid as Novel Inhibitor of SARS-CoV-2 Main Protease Through Virtual Screening Approaches.通过虚拟筛选方法鉴定松萝酸的吡唑衍生物作为新型严重急性呼吸综合征冠状病毒2主蛋白酶抑制剂
Mol Biotechnol. 2024 Apr;66(4):696-706. doi: 10.1007/s12033-023-00667-5. Epub 2023 Feb 8.
3
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.靶向 SARS-CoV-2 主蛋白酶:一项计算药物再利用研究。
Arch Med Res. 2021 Jan;52(1):38-47. doi: 10.1016/j.arcmed.2020.09.013. Epub 2020 Sep 17.
4
Potential SARS-CoV-2 protease M inhibitors: repurposing FDA-approved drugs.潜在的 SARS-CoV-2 蛋白酶 M 抑制剂:重新利用 FDA 批准的药物。
Phys Biol. 2021 Feb 9;18(2):025001. doi: 10.1088/1478-3975/abcb66.
5
Exploring epigenetic drugs as potential inhibitors of SARS-CoV-2 main protease: a docking and MD simulation study.探讨表观遗传药物作为 SARS-CoV-2 主蛋白酶潜在抑制剂的研究:对接和 MD 模拟研究。
J Biomol Struct Dyn. 2024 Aug;42(13):6892-6903. doi: 10.1080/07391102.2023.2236714. Epub 2023 Jul 17.
6
Investigation of bio-active Amaryllidaceae alkaloidal small molecules as putative SARS-CoV-2 main protease and host TMPRSS2 inhibitors: interpretation by simulation study.基于模拟研究的新型 SARS-CoV-2 主要蛋白酶和宿主 TMPRSS2 抑制剂候选物——石蒜科生物活性生物碱小分子的研究
J Biomol Struct Dyn. 2024 Sep;42(14):7107-7127. doi: 10.1080/07391102.2023.2238065. Epub 2023 Jul 24.
7
Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M Protease.利用定量构效关系、对接和分子动力学对严重急性呼吸综合征冠状病毒2 M蛋白酶的潜在抑制剂进行药物再利用研究
Molecules. 2020 Nov 6;25(21):5172. doi: 10.3390/molecules25215172.
8
Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease.基于分子对接的新冠病毒主蛋白酶可能抑制剂的虚拟筛选。
Microb Pathog. 2020 Nov;148:104365. doi: 10.1016/j.micpath.2020.104365. Epub 2020 Jun 30.
9
Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.从天然来源开发针对冠状病毒蛋白酶的有效治疗分子。
Int J Mol Sci. 2021 Aug 30;22(17):9431. doi: 10.3390/ijms22179431.
10
Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2.计算评估蛋白酶抑制剂对 SARS-CoV-2 的选择性。
Int J Mol Sci. 2021 Feb 19;22(4):2065. doi: 10.3390/ijms22042065.

引用本文的文献

1
Novel spirooxindole-triazole derivatives: unveiling [3+2] cycloaddition reactivity through molecular electron density theory and investigating their potential cytotoxicity against HepG2 and MDA-MB-231 cell lines.新型螺环氧化吲哚-三唑衍生物:通过分子电子密度理论揭示[3+2]环加成反应活性并研究其对HepG2和MDA-MB-231细胞系的潜在细胞毒性。
Front Chem. 2024 Sep 30;12:1460384. doi: 10.3389/fchem.2024.1460384. eCollection 2024.
2
Engineering of the Central Core on DBD-Based Materials with Improved Power-Conversion Efficiency by Using the DFT Approach.通过密度泛函理论方法对基于双功能二烯丙基二甲基氯化铵的材料进行中心核工程设计以提高功率转换效率
ACS Omega. 2024 Mar 18;9(27):29205-29225. doi: 10.1021/acsomega.3c09215. eCollection 2024 Jul 9.
3

本文引用的文献

1
Identification of potential inhibitors of SARS-CoV-2 main protease from compounds: A molecular docking study.从化合物中鉴定严重急性呼吸综合征冠状病毒2主要蛋白酶的潜在抑制剂:一项分子对接研究。
Chem Phys Lett. 2020 Sep;754:137751. doi: 10.1016/j.cplett.2020.137751. Epub 2020 Jun 30.
2
Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2.鉴定抗击 COVID-19 的潜在药物候选物:使用 SARS-CoV-2 的主要蛋白酶(mpro)进行的结构研究。
J Biomol Struct Dyn. 2021 Oct;39(17):6649-6659. doi: 10.1080/07391102.2020.1798286. Epub 2020 Aug 3.
3
Molecular docking, simulation and MM-PBSA studies of compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment.
ADME Study, Molecular Docking, Elucidating the Selectivities and the Mechanism of [4 + 2] Cycloaddition Reaction Between (E)-N ((dimethylamino)methylene)benzothioamide and (S)-3-acryloyl-4-phenyloxazolidin-2-one.
ADME研究、分子对接、阐明(E)-N-((二甲氨基)亚甲基)苯并硫代酰胺与(S)-3-丙烯酰基-4-苯基恶唑烷-2-酮之间[4+2]环加成反应的选择性和机理
Mol Biotechnol. 2025 Mar;67(3):1065-1076. doi: 10.1007/s12033-024-01105-w. Epub 2024 Mar 8.
4
Pyrazoline and Analogs: Substrate-based Synthetic Strategies.吡唑啉及其类似物:基于底物的合成策略。
Curr Org Synth. 2024;21(7):823-836. doi: 10.2174/1570179421666230822100043.
5
Explaining the selectivities and the mechanism of [3+2] cycloloaddition reaction between isoalantolactone and diazocyclopropane.解释异土木香内酯与重氮环丙烷之间[3+2]环加成反应的选择性及反应机理。
J Mol Model. 2023 Aug 15;29(9):280. doi: 10.1007/s00894-023-05688-0.
6
Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models.分子对接作为一种重新利用药物对抗 COVID-19 的潜在方法:系统综述与新型药效团模型
Curr Pharmacol Rep. 2022;8(3):212-226. doi: 10.1007/s40495-022-00285-w. Epub 2022 Apr 1.
分子对接、模拟和 MM-PBSA 研究化合物:一种计算方法,旨在寻找治疗 COVID-19 的潜在天然抗病毒药物。
J Biomol Struct Dyn. 2021 Aug;39(12):4225-4233. doi: 10.1080/07391102.2020.1775129. Epub 2020 Jun 12.
4
Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches.使用分子建模方法鉴定针对新冠病毒主要蛋白酶的植物化学抑制剂。
J Biomol Struct Dyn. 2021 Jul;39(10):3760-3770. doi: 10.1080/07391102.2020.1772112. Epub 2020 Jun 4.
5
Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking.基于分子对接的 SARS-CoV-2(COVID-19)冠状病毒拮抗剂的计算筛选。
Int J Antimicrob Agents. 2020 Aug;56(2):106012. doi: 10.1016/j.ijantimicag.2020.106012. Epub 2020 May 8.
6
A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease.通过 SARS-CoV-2 刺突糖蛋白和 3CL 蛋白酶的计算机分子对接模型寻找治疗 COVID-19 的药物。
Travel Med Infect Dis. 2020 May-Jun;35:101646. doi: 10.1016/j.tmaid.2020.101646. Epub 2020 Apr 12.
7
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic.正在进行的 COVID-19 大流行管理临床试验。
Trends Pharmacol Sci. 2020 Jun;41(6):363-382. doi: 10.1016/j.tips.2020.03.006. Epub 2020 Apr 9.
8
In silico studies on therapeutic agents for COVID-19: Drug repurposing approach.针对 COVID-19 的治疗药物的计算机研究:药物再利用方法。
Life Sci. 2020 Jul 1;252:117652. doi: 10.1016/j.lfs.2020.117652. Epub 2020 Apr 9.
9
Structure of M from SARS-CoV-2 and discovery of its inhibitors.SARS-CoV-2 M 结构与抑制剂的发现
Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9.
10
Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19.洛匹那韦、奥司他韦和利托那韦与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白酶结合用于治疗2019冠状病毒病(COVID-19)的药物重新利用和协同作用的计算研究
J Biomol Struct Dyn. 2021 Apr;39(7):2673-2678. doi: 10.1080/07391102.2020.1752802. Epub 2020 Apr 16.